SPRYCEL (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the SPRYCEL drug offered from E.R. Squibb & Sons, L.L.C.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
NON-PROPRIETARY NAME: | dasatinib |
SUBSTANCE NAME: | DASATINIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-06-27 |
END MARKETING DATE: | 0000-00-00 |
SPRYCEL HUMAN PRESCRIPTION DRUG Details:
Item Description | SPRYCEL from E.R. Squibb & Sons, L.L.C. |
LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 70(mg/1) |
START MARKETING DATE: | 2006-06-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0003-0524_f0719d03-ac55-413a-aea2-677a5cde1ff3 |
PRODUCT NDC: | 0003-0524 |
APPLICATION NUMBER: | NDA021986 |
Other DASATINIB Pharmaceutical Manufacturers / Labelers: